The FDA approved Journavx (suzetrigine) oral tablets for the management of moderate to severe acute pain in adults. Journavx pain management is the first drug in a new class of pain management medications. Journa...
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.